Evaluation of chemical stability of St. John's wort commercial extract and some preparations

被引:77
作者
Bilia, AR [1 ]
Bergonzi, MC [1 ]
Morgenni, F [1 ]
Mazzi, G [1 ]
Vincieri, FF [1 ]
机构
[1] Univ Florence, Dept Pharmaceut Sci, I-50121 Florence, Italy
关键词
St. John's wort (Hypericum perforatum L.); commercial extract and capsules; HPLC; flavonols; hyperforins and hypericins; thermal and photostability;
D O I
10.1016/S0378-5173(00)00660-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thermal and photostability of a commercial dried extract and capsules of St. John's wort (Hypericum perforatum L.) were evaluated under the ICH test conditions. The extract was considered as drug substance and its preparations as drug products. In addition, capsules of different colours corresponding to different opaficient and pigment contents were also evaluated as primary package of drug product and the tests in the secondary pack were performed with amber containers, as well. A selective high-performance liquid chromatography (HPLC) for determination of stability of all the characteristic constituents, namely flavonols, hyperforins and hypericins, was carried out. Photostability testing showed all the constituents to be photosensitive in the tested conditions. However, different opaficients and pigments present in the capsules influenced the stability of the different classes of constituents. Amber containers suggested as secondary packages influenced only in part the photostability of the investigated constituents. Long-term thermal stability testing showed a very low (less than 4 months) hyperforins and hypericins t(90), even if ascorbic and citric acids were added to the formulation. From the results we have obtained it is clear that for St. John's wort preparations, a mere translation of the ICH guidelines to the field of herbal products, as suggested by the WPHMP of the EMEA, cannot be accepted. A revision and adaptation of the storage conditions should be elaborated. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 21 条
[1]  
ADAMSKI R, 1971, FARMACJA POLSKA, V3, P237
[2]  
BRANTNER A, 1994, SCI PHARM, V62, P7
[3]   Identification by high-performance liquid chromatography diode array detection mass spectrometry and quantification by high-performance liquid chromatography UV absorbance detection of active constituents of Hypericum perforatum [J].
Brolis, M ;
Gabetta, B ;
Fuzzati, N ;
Pace, R ;
Panzeri, F ;
Peterlongo, F .
JOURNAL OF CHROMATOGRAPHY A, 1998, 825 (01) :9-16
[4]   Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat [J].
Chatterjee, S ;
Filippov, V ;
Lishko, P ;
Maximyuk, O ;
Nöldner, M ;
Krishtal, O .
LIFE SCIENCES, 1999, 65 (22) :2395-2405
[5]   Hyperforin as a possible antidepressant component of hypericum extracts [J].
Chatterjee, SS ;
Bhattacharya, SK ;
Wonnemann, M ;
Singer, A ;
Müller, WE .
LIFE SCIENCES, 1998, 63 (06) :499-510
[6]   Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility [J].
Chatterjee, SS ;
Noldner, M ;
Koch, E ;
Erdelmeier, C .
PHARMACOPSYCHIATRY, 1998, 31 :7-15
[7]   Variations in hypericin concentrations in Hypericum perforatum L and commercial products [J].
Constantine, GH ;
Karchesy, J .
PHARMACEUTICAL BIOLOGY, 1998, 36 (05) :365-367
[8]  
EMEA, 1999, WORK PART HERB MED P, P48
[9]   Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex [J].
Gobbi, M ;
Dalla Valle, F ;
Ciapparelli, C ;
Diomede, L ;
Morazzoni, P ;
Verotta, L ;
Caccia, S ;
Cervo, L ;
Mennini, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 360 (03) :262-269
[10]  
Harrer G, 1994, Phytomedicine, V1, P3, DOI 10.1016/S0944-7113(11)80016-4